Our idea is to create regenerative medicine for a variety of diseases related to muscle injuries, the vascular system and haematological disorders.
Our technology produces high quality cell therapy products from the placenta after birth, which, in response to a specific medical condition, releases therapeutic proteins that stimulate the body's own healing process.